HAYA Therapeutics gets $65M for 'dark genome' work following last year's Lilly pact
Summary
Af\xadter work\xading off $20 mil\xadlion in seed fund\xading for about four years, HAYA Ther\xada\xadpeu\xadtics tapped the fund\xading well and came back with $65 mil\xadlion to Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected